Aarey Drugs & Pharmaceuticals Ltd
22 February 2025 13:39|BSE : 524412|NSE : AAREYDRUGS|ISIN : INE198H01019
22 February 2025 13:39|BSE : 524412
NSE : AAREYDRUGS|ISIN : INE198H01019
Aarey Drugs & Pharmaceuticals is manufacturing the following intermediates- Mono Methyl Urea, Die Methyl Urea. Ortho Para Nitro Anisole, 2 Bromomethyl 1,3 Dioxalane & Uracile & in Active Pharma Ingredients the company is involved in manufacturing Metformin HCL, Mefenamic Acid & Doxophylline. Besides we intend to increase capacity of all the products based upon the demand of the product and also plans to do backward & forward integration of products such as DMA-HCL, Ortho chloro benzoic acid and further API's like theophylline.
Aarey Drugs & Pharmaceuticals is manufacturing the following intermediates- Mono Methyl Urea, Die Methyl Urea. Ortho Para Nitro Anisole, 2 Bromomethyl 1,3 Dioxalane & Uracile & in Active Pharma Ingredients the company is involved in manufacturing Metformin HCL, Mefenamic Acid & Doxophylline. Besides we intend to increase capacity of all the products based upon the demand of the product and also plans to do backward & forward integration of products such as DMA-HCL, Ortho chloro benzoic acid and further API's like theophylline.
FAQs
How to buy Aarey Drugs & Pharmaceuticals Ltd shares?
What is the current Market Cap of Aarey Drugs & Pharmaceuticals Ltd?
What is the current PE and PB ratio of Aarey Drugs & Pharmaceuticals Ltd?
Open Free Demat Account
Kickstart your investment journey
